Lyra Therapeutics (LYRA) Current Assets (2021 - 2025)
Historic Current Assets for Lyra Therapeutics (LYRA) over the last 5 years, with Q3 2025 value amounting to $23.0 million.
- Lyra Therapeutics' Current Assets fell 5771.99% to $23.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.0 million, marking a year-over-year decrease of 5771.99%. This contributed to the annual value of $43.0 million for FY2024, which is 5895.38% down from last year.
- According to the latest figures from Q3 2025, Lyra Therapeutics' Current Assets is $23.0 million, which was down 5771.99% from $31.1 million recorded in Q2 2025.
- Over the past 5 years, Lyra Therapeutics' Current Assets peaked at $122.4 million during Q2 2022, and registered a low of $23.0 million during Q3 2025.
- For the 5-year period, Lyra Therapeutics' Current Assets averaged around $72.6 million, with its median value being $69.4 million (2024).
- Per our database at Business Quant, Lyra Therapeutics' Current Assets surged by 11041.99% in 2022 and then crashed by 6209.32% in 2025.
- Lyra Therapeutics' Current Assets (Quarter) stood at $47.9 million in 2021, then skyrocketed by 110.42% to $100.8 million in 2022, then grew by 3.96% to $104.8 million in 2023, then plummeted by 58.95% to $43.0 million in 2024, then tumbled by 46.5% to $23.0 million in 2025.
- Its last three reported values are $23.0 million in Q3 2025, $31.1 million for Q2 2025, and $33.9 million during Q1 2025.